Popular weight-loss drugs may help protect against a deadly disease, doctor says

GLP-1 medications have transformed diabetes and obesity treatment, but emerging research suggests their benefits could extend far beyond those purposes — potentially even aiding in cancer prevention and survival. Dr. Loren Rourke, a Texas-based board-certified breast cancer surgeon, author and speaker, said growing research suggests glucagon-like peptide-1 (GLP-1) medications — including Ozempic and Wegovy — may be associated with a lower risk of cancer diagnoses and recurrence. She pointed to f